Search Results - "Chow, E K"

Survival Benefit of Primary Deceased Donor Transplantation With High‐KDPI Kidneys by Massie, A. B., Luo, X., Chow, E. K. H., Alejo, J. L., Desai, N. M., Segev, D. L.

“…The Kidney Donor Profile Index (KDPI) has been introduced as an aid to evaluating deceased donor kidney offers, but the relative benefit of high‐KDPI kidney…”
Get full text

E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60 by Subbaiah, V K, Zhang, Y, Rajagopalan, D, Abdullah, L N, Yeo-Teh, N S L, Tomaić, V, Banks, L, Myers, M P, Chow, E K, Jha, S

“…Tat-interacting protein of 60 kDa (TIP60) is an essential lysine acetyltransferase implicated in transcription, DNA damage response and apoptosis. TIP60…”
Get full text

The Impact of Redistricting Proposals on Health Care Expenditures for Liver Transplant Candidates and Recipients by Gentry, S.E., Chow, E.K.H., Dzebisashvili, N., Schnitzler, M.A., Lentine, K.L., Wickliffe, C.E., Shteyn, E., Pyke, J., Israni, A., Kasiske, B., Segev, D.L., Axelrod, D.A.

“…Redistricting, which means sharing organs in novel districts developed through mathematical optimization, has been proposed to reduce pervasive geographic…”
Get full text

Identifying Appropriate Recipients for CDC Infectious Risk Donor Kidneys by Chow, E. K. H., Massie, A. B., Muzaale, A. D., Singer, A. L., Kucirka, L. M., Montgomery, R. A., Lehmann, H. P., Segev, D. L.

“…Over 10% of deceased donors in 2011 met PHS/CDC criteria for infectious risk donor (IRD), and discard rates are significantly higher for kidneys from these…”
Get full text

The XMM-SERVS survey: new XMM–Newton point-source catalogue for the XMM-LSS field by Chen (陳建廷), C-T J, Brandt, W N, Luo, B, Ranalli, P, Yang, G, Alexander, D M, Bauer, F E, Kelson, D D, Lacy, M, Nyland, K, Tozzi, P, Vito, F, Cirasuolo, M, Gilli, R, Jarvis, M J, Lehmer, B D, Paolillo, M, Schneider, D P, Shemmer, O, Smail, I, Sun, M, Tanaka, M, Vaccari, M, Vignali, C, Xue, Y Q, Banerji, M, Chow, K E, Häußler, B, Norris, R P, Silverman, J D, Trump, J R

“…We present an X-ray point-source catalogue from the XMM-Large Scale Structure (XMMLSS) survey region, one of the XMM-Spitzer Extragalactic Representative…”
Get full text

ATLAS – I. Third release of 1.4 GHz mosaics and component catalogues by Franzen, T. M. O., Banfield, J. K., Hales, C. A., Hopkins, A., Norris, R. P., Seymour, N., Chow, K. E., Herzog, A., Huynh, M. T., Lenc, E., Mao, M. Y., Middelberg, E.

“…We present the third data release from the Australia Telescope Large Area Survey. These data combine the observations at 1.4 GHz before and after upgrades to…”
Get full text

A Risk Index for Living Donor Kidney Transplantation by Massie, A. B., Leanza, J., Fahmy, L. M., Chow, E. K. H., Desai, N. M., Luo, X., King, E. A., Bowring, M. G., Segev, D. L.

“…Choosing between multiple living kidney donors, or evaluating offers in kidney paired donation, can be challenging because no metric currently exists for…”
Get full text

Radio Galaxy Zoo: host galaxies and radio morphologies derived from visual inspection by Banfield, J. K., Wong, O. I., Willett, K. W., Norris, R. P., Rudnick, L., Shabala, S. S., Simmons, B. D., Snyder, C., Garon, A., Seymour, N., Middelberg, E., Andernach, H., Lintott, C. J., Jacob, K., Kapińska, A. D., Mao, M. Y., Masters, K. L., Jarvis, M. J., Schawinski, K., Paget, E., Simpson, R., Klöckner, H.-R., Bamford, S., Burchell, T., Chow, K. E., Cotter, G., Fortson, L., Heywood, I., Jones, T. W., Kaviraj, S., López-Sánchez, Á. R., Maksym, W. P., Polsterer, K., Borden, K., Hollow, R. P., Whyte, L.

“…We present results from the first 12 months of operation of Radio Galaxy Zoo, which upon completion will enable visual inspection of over 170 000 radio sources…”
Get full text

Early Changes in Liver Distribution Following Implementation of Share 35 by Massie, A. B., Chow, E. K. H., Wickliffe, C. E., Luo, X., Gentry, S. E, Mulligan, D. C., Segev, D. L.

“…ABSTRACT In June 2013, a change to the liver waitlist priority algorithm was implemented. Under Share 35, regional candidates with MELD ≥ 35 receive higher…”
Get full text

Scintigraphic Assessment of Deposition of Radiolabeled Fluticasone Delivered from a Nebulizer and Metered Dose Inhaler in 10 Healthy Dogs by Chow, K.E., Tyrrell, D., Yang, M., Abraham, L.A., Anderson, G.A., Mansfield, C.S.

“…Background Aerosolized medications are increasingly being used to treat respiratory diseases in dogs. No previous studies assessing respiratory tract…”
Get full text

ATLAS 1.4 GHz Data Release 2 – I. Observations of the CDF-S and ELAIS-S1 fields and methods for constructing differential number counts by Hales, C. A., Norris, R. P., Gaensler, B. M., Middelberg, E., Chow, K. E., Hopkins, A. M., Huynh, M. T., Lenc, E., Mao, M. Y.

“…This is the first of two papers describing the second data release (DR2) of the Australia Telescope Large Area Survey at 1.4 GHz, which comprises deep…”
Get full text

Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35 by Chow, E. K. H., Massie, A. B., Luo, X., Wickliffe, C. E., Gentry, S. E., Cameron, A. M., Segev, D. L.

“…Under Share 35, deceased donor (DD) livers are offered regionally to candidates with Model for End‐Stage Liver Disease (MELD) scores ≥35 before being offered…”
Get full text

Where the Sun Shines: Industry's Payments to Transplant Surgeons by Ahmed, R., Chow, E. K., Massie, A. B., Anjum, S., King, E. A., Orandi, B. J., Bae, S., Nicholas, L. H., Lonze, B. E., Segev, D. L.

“…The Open Payments Program (OPP) was recently implemented to publicly disclose industry payments to physicians, with the goal of enabling patient awareness of…”
Get full text

CLINICAL APPLICATION OF AN EX‐VIVO PLATFORM TO GUIDE THE CHOICE OF DRUG COMBINATIONS IN RELAPSED/REFRACTORY LYMPHOMA; A PROSPECTIVE STUDY by De Mel, S, Goh, J, Rashid, M. B. M. A, Zhang, X. Y, Jaynes, P, Liu, X, Poon, L, Chan, E, Lee, J, Chee, Y. L, Koh, L. P, Tan, L. K, Soh, T. G, Yuen, Y. C, Loi, Hoi‐Y, Ng, Siok‐B, Goh, X, Tan, D, Cheah, D. M. Z, Pang, W. L, Huang, D, Chan, J. Y, Somasundaram, N, Tang, T, Lim, S. T, Ong, C. K, Chng, W.‐J, Chow, E. K, Jeyasekharan, A. D

Get full text

Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection by Perry, Andrea K, Chow, Edward K, Goodnough, Julia B, Yeh, Wen-Chen, Cheng, Genhong

“…TANK-binding kinase-1 (TBK1) and the inducible IkappaB kinase (IKK-i) have been shown recently to activate interferon (IFN) regulatory factor-3 (IRF3), the…”
Get full text

Toll-like receptors induce a phagocytic gene program through p38 by Doyle, Sean E, O'Connell, Ryan M, Miranda, Gustavo A, Vaidya, Sagar A, Chow, Edward K, Liu, Philip T, Suzuki, Shinobu, Suzuki, Nobutaka, Modlin, Robert L, Yeh, Wen-Chen, Lane, Timothy F, Cheng, Genhong

“…Toll-like receptor (TLR) signaling and phagocytosis are hallmarks of macrophage-mediated innate immune responses to bacterial infection. However, the…”
Get full text

Quantifying Renal Allograft Loss Following Early Antibody‐Mediated Rejection by Orandi, B. J., Chow, E. H. K., Hsu, A., Gupta, N., Van Arendonk, K. J., Garonzik‐Wang, J. M., Montgomery, J. R., Wickliffe, C., Lonze, B. E., Bagnasco, S. M., Alachkar, N., Kraus, E. S., Jackson, A. M., Montgomery, R. A., Segev, D. L.

“…Unlike antibody‐mediated rejection (AMR) with clinical features, it remains unclear whether subclinical AMR should be treated, as its effect on allograft loss…”
Get full text

Toll-Like Receptor 3 Mediates a More Potent Antiviral Response Than Toll-Like Receptor 4 by Doyle, Sean E, O'Connell, Ryan, Vaidya, Sagar A, Chow, Edward K, Yee, Kathleen, Cheng, Genhong

“…We have recently described an IFN regulatory factor 3-mediated antiviral gene program that is induced by both Toll-like receptor (TLR)3 and TLR4 ligands. In…”
Get full text

Structure of the cinnamyl-alcohol dehydrogenase gene family in rice and promoter activity of a member associated with lignification by Tobias, C.M, Chow, E.K

“…Analysis of lignification in rice has been facilitated by the availability of the recently completed rice genome sequence, and rice will serve as an important…”
Get full text

Identification of an effective chemotherapy and DNA damage response inhibitor combination for diffuse large b cell lymphoma by Chan, A., Anbuselvan, A., Upadhyayula, S.S., Jemimah, S., Jaynes, P., Hoppe, M.M., Wardyn, J.D., Goh, J., Bertolazzi, G., Foiani, M., O’Connor, M.J., Chow, E.K., Tripodo, C., Jeyasekharan, A.D.

Get full text